|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Graeser, Monika; Harbeck, Nadia; Gluz, Oleg; Wuerstlein, Rachel; Eulenburg, Christine zu; Schumacher, Claudia; Grischke, Eva -Maria; Forstbauer, Helmut; Dimpfl, Moritz; Braun, Michael; Christgen, Matthias; Kreipe, Hans Heinrich; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Kuemmel, Sherko und Nitz, Ulrike
(2021):
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials.
In: Breast, Bd. 59: S. 58-66
Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Herzog, Christopher; Umutlu, Lale; Frydrychowicz, Alex; Rjosk-Dendorfer, Dorothea; Wuerstlein, Rachel; Culemann, Ralph; Eulenburg, Christine; Adams, Jascha; Nitzsche, Henrik; Prange, Anna; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike
(2021):
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.
In: Breast Cancer Research, Bd. 23, Nr. 1, 36
Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Wuerstlein, Rachel; Kuemmel, Sherko; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Christgen, Matthias; Adams, Jascha; Nitzsche, Henrik; Just, Marianne; Fischer, Hans Holger; Aktas, Bahriye; Potenberg, Jochem; Schumann, Raquel von; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike
(2021):
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials.
In: International Journal of Cancer, Bd. 148, Nr. 10: S. 2614-2627
Harbeck, Nadia; Schumann, Raquel von; Kates, Ronald Ernest; Braun, Michael; Kuemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; Haas, Sanne Lysbet de; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich und Gluz, Oleg
(2021):
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.
In: Cancers, Bd. 13, Nr. 19, 4884
Wuerstlein, Rachel; Harbeck, Nadia; Grischke, Eva-Maria; Forstmeyer, Dirk; Schumann, Raquel von; Krabisch, Petra; Ludtke-Heckenkamp, Kerstin; Stefek, Andrea; Stoetzer, Oliver; Grafe, Andrea; Kaltenecker, Gabriele; Forstbauer, Helmut; Augustin, Doris; Schrader, Iris; Tio, Joke; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E. und Graeser, Monika Karla
(2021):
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
In: Breast Care, Bd. 16, Nr. 1: S. 50-58
Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Schumann, Raquel von und Harbeck, Nadia
(2018):
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
In: Jnci-Journal of the National Cancer Institute, Bd. 110, Nr. 6, djx258: S. 628-637
Harbeck, Nadia; Gluz, Oleg; Christgen, Matthias; Kates, Ronald Ernest; Braun, Michael; Küemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Krämer, Stefan; Kleine-Tebbe, Anke; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Schumann, Raquel von; Liedtke, Cornelia; Grischke, Eva-Maria; Schumacher, Johannes; Würstlein, Rachel; Kreipe, Hans Heinrich und Nitz, Ulrike Anneliese
(2017):
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2-and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.
In: Journal of Clinical Oncology, Bd. 35, Nr. 26: S. 3046-3056